{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:16:22Z","timestamp":1791598582609,"version":"4.3.4"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Res Med Sci"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4103\/1735-1995.165964","type":"journal-article","created":{"date-parts":[[2015,9,22]],"date-time":"2015-09-22T15:55:21Z","timestamp":1442937321000},"page":"585","source":"Crossref","is-referenced-by-count":15,"title":["The effectiveness of using misoprostol with and without letrozole for successful medical abortion: A randomized placebo-controlled clinical trial"],"prefix":"10.4103","volume":"20","author":[{"given":"Faezah","family":"Farhat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Naghshineh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Allame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1735-1995.165964-1","first-page":"175","volume-title":"Unwanted pregnancy and associated factors among Nigerian women","author":"Sedgh","year":"2006","journal-title":"Int Fam Plan Perspect"},{"key":"key-10.4103\/1735-1995.165964-2","first-page":"1338","volume-title":"Induced abortion: Estimated rates and trends worldwide","author":"Sedgh","year":"2007","journal-title":"Lancet"},{"key":"key-10.4103\/1735-1995.165964-3","first-page":"90","volume-title":"Unsafe abortion in 2008: Global and regional levels and trends","author":"Shah","year":"2010","journal-title":"Reprod Health Matters"},{"key":"key-10.4103\/1735-1995.165964-4","first-page":"47","volume-title":"Morbidity and mortality due to unsafe abortion in Pakistan","author":"Shaikh","year":"2010","journal-title":"Int J Gynaecol Obstet"},{"key":"key-10.4103\/1735-1995.165964-5","first-page":"398","volume-title":"The development of Australian abortion laws in a worldwide trend, free and legal practices of abortion and a glance at abortion laws in Iran","author":"Hosseini","year":"2007","journal-title":"J Reprod Infertil"},{"key":"key-10.4103\/1735-1995.165964-6","first-page":"299","volume-title":"The necessity of a comprehensive study on abortion in Iran","author":"Behjati","year":"2005","journal-title":"J Reprod Infertil"},{"key":"key-10.4103\/1735-1995.165964-7","first-page":"38","volume-title":"Study on abortion cases referred to the Forensic Medicine Center of Ardebil city","author":"Rustamnezhad","year":"2011","journal-title":"Health Care J"},{"key":"key-10.4103\/1735-1995.165964-8","doi-asserted-by":"crossref","unstructured":"ACOG. ACOG practice bulletin. Clinical management guidelines of obstetrician-gynecologists. Number 67, October 2005. Medical management of abortion. Obstet Gynecol 2005;106:871-82.","DOI":"10.1097\/00006250-200510000-00051"},{"key":"key-10.4103\/1735-1995.165964-9","first-page":"431","volume-title":"Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: A comparative trial of mifepristone-misoprostol versus surgical abortion","author":"Winikoff","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"key-10.4103\/1735-1995.165964-10","first-page":"505","volume-title":"Randomized study of sulprostone versus misoprostol in the cervical preparation before elective abortion in nulliparous women","author":"Schaub","year":"1995","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"key-10.4103\/1735-1995.165964-11","first-page":"S178","volume-title":"Misoprostol for the termination of pregnancy with a live fetus at 13 to 26 weeks","author":"Ho","year":"2007","journal-title":"Int J Gynaecol Obstet"},{"key":"key-10.4103\/1735-1995.165964-12","first-page":"65","volume-title":"Sublingual versus vaginal misoprostol for second trimester termination: A randomized clinical trial","author":"Tanha","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"key-10.4103\/1735-1995.165964-13","first-page":"106","volume-title":"Comparison of vaginal and sublingual misoprostol for second trimester abortion: Randomized controlled equivalence trial","author":"von","year":"2009","journal-title":"Hum Reprod"},{"key":"key-10.4103\/1735-1995.165964-14","first-page":"1304","volume-title":"Mifepristone in second-trimester medical abortion: A randomized controlled trial","author":"Kapp","year":"2007","journal-title":"Obstet Gynecol"},{"key":"key-10.4103\/1735-1995.165964-15","first-page":"628","volume-title":"A prospective double-blinded, randomized, placebo-controlled trial on the use of letrozole pretreatment with misoprostol for second-trimester medical abortion","author":"Lee","year":"2011","journal-title":"Contraception"},{"key":"key-10.4103\/1735-1995.165964-16","first-page":"317","volume-title":"Misoprostol with or without letrozole pretreatment for termination of pregnancy: A randomized controlled trial","author":"Lee","year":"2011","journal-title":"Obstet Gynecol"},{"key":"key-10.4103\/1735-1995.165964-17","first-page":"229","volume-title":"Single-dose administration of an aromatase inhibitor for ovarian stimulation","author":"Mitwally","year":"2005","journal-title":"Fertil Steril"},{"key":"key-10.4103\/1735-1995.165964-18","first-page":"277","volume-title":"A new era in ovulation induction","author":"Holzer","year":"2006","journal-title":"Fertil Steril"},{"key":"key-10.4103\/1735-1995.165964-19","first-page":"2962","volume-title":"An effective regimen for early medical abortion: A report of 2000 consecutive cases","author":"Ashok","year":"1998","journal-title":"Hum Reprod"},{"key":"key-10.4103\/1735-1995.165964-20","first-page":"1","volume-title":"Low-dose mifepristone 200 mg and vaginal misoprostol for abortion","author":"Schaff","year":"1999","journal-title":"Contraception"},{"key":"key-10.4103\/1735-1995.165964-21","first-page":"1367","volume-title":"Misoprostol abortion: Ultrasonography versus Beta-hCG testing for verification of effectiveness","author":"Behnamfar","year":"2013","journal-title":"Pak J Med Sci"},{"key":"key-10.4103\/1735-1995.165964-22","first-page":"511","volume-title":"Randomized comparison of second trimester pregnancy termination utilizing saline moistened or dry misoprostol","author":"Yilmaz","year":"2007","journal-title":"Arch Gynecol Obstet"},{"key":"key-10.4103\/1735-1995.165964-23","first-page":"709","volume-title":"A comparison of two regimens of intravaginal misoprostol for termination of second trimester pregnancy: A randomized comparative trial","author":"Wong","year":"2000","journal-title":"Hum Reprod"},{"key":"key-10.4103\/1735-1995.165964-24","first-page":"207","volume-title":"Vaginal misoprostol compared with vaginal gemeprost in termination of second trimester pregnancy.A randomized trial","author":"Wong","year":"1998","journal-title":"Contraception"},{"key":"key-10.4103\/1735-1995.165964-25","first-page":"3062","volume-title":"A prospective randomized comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12-20 weeks gestation","author":"Tang","year":"2005","journal-title":"Hum Reprod"},{"key":"key-10.4103\/1735-1995.165964-26","first-page":"311","volume-title":"A randomized comparative study on vaginal administration of acetic acid-moistened versus dry misoprostol for mid-trimester pregnancy termination","author":"Bhattacharjee","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"key-10.4103\/1735-1995.165964-27","first-page":"763","volume-title":"A pilot study on the use of a 7-day course of letrozole followed by misoprostol for the termination of early pregnancy up to 63 days","author":"Yeung","year":"2012","journal-title":"Contraception"},{"key":"key-10.4103\/1735-1995.165964-28","first-page":"291","volume-title":"A pilot study on the combined use of letrozole, mifepristone and misoprostol in termination of first trimester pregnancy up to 9 weeks\u2032 gestation","author":"Chai","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key-10.4103\/1735-1995.165964-29","first-page":"41","volume-title":"Comparison of sublingual and vaginal misoprostol for second-trimester pregnancy terminations","author":"Milani","year":"2014","journal-title":"J Family Reprod Health"},{"key":"key-10.4103\/1735-1995.165964-30","first-page":"1186","volume-title":"Misoprostol dose and route after mifepristone for early medical abortion: A randomised controlled noninferiority trial","author":"von","year":"2010","journal-title":"BJOG"},{"key":"key-10.4103\/1735-1995.165964-31","first-page":"213","volume-title":"Role of sublingual misoprostol for cervical ripening prior to vacuum aspiration in first trimester interruption of pregnancy","author":"Saxena","year":"2003","journal-title":"Contraception"},{"key":"key-10.4103\/1735-1995.165964-32","first-page":"1001","volume-title":"A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy","author":"Tang","year":"2004","journal-title":"BJOG"},{"key":"key-10.4103\/1735-1995.165964-33","first-page":"62","volume-title":"A pilot study on the use of letrozole with either misoprostol or mifepristone for termination of pregnancy up to 63 days","author":"Lee","year":"2011","journal-title":"Contraception"}],"container-title":["Journal of Research in Medical Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:28:48Z","timestamp":1786649328000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1735-1995.165964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"alternative-id":["165964"],"URL":"https:\/\/doi.org\/10.4103\/1735-1995.165964","relation":{},"ISSN":["1735-1995"],"issn-type":[{"value":"1735-1995","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}